447 related articles for article (PubMed ID: 25761845)
1. Medical cannabis vs. synthetic cannabinoids: What does the future hold?
Bolognini D; Ross RA
Clin Pharmacol Ther; 2015 Jun; 97(6):568-70. PubMed ID: 25761845
[TBL] [Abstract][Full Text] [Related]
2. Medical cannabis and cannabinoids in rheumatology: where are we now?
Sarzi-Puttini P; Batticciotto A; Atzeni F; Bazzichi L; Di Franco M; Salaffi F; Marotto D; Ceribelli A; Ablin JN; Hauser W
Expert Rev Clin Immunol; 2019 Oct; 15(10):1019-1032. PubMed ID: 31512536
[No Abstract] [Full Text] [Related]
3. [Potential applications of marijuana and cannabinoids in medicine].
Zdrojewicz Z; Pypno D; Cabała K; Bugaj B; Waracki M
Pol Merkur Lekarski; 2014 Oct; 37(220):248-52. PubMed ID: 25518584
[TBL] [Abstract][Full Text] [Related]
4. Medical Marijuana and Chronic Pain: a Review of Basic Science and Clinical Evidence.
Jensen B; Chen J; Furnish T; Wallace M
Curr Pain Headache Rep; 2015 Oct; 19(10):50. PubMed ID: 26325482
[TBL] [Abstract][Full Text] [Related]
5. Cannabis in cancer care.
Abrams DI; Guzman M
Clin Pharmacol Ther; 2015 Jun; 97(6):575-86. PubMed ID: 25777363
[TBL] [Abstract][Full Text] [Related]
6. Homology modeling of cannabinoid receptors: discovery of cannabinoid analogues for therapeutic use.
Chang CE; Ai R; Gutierrez M; Marsella MJ
Methods Mol Biol; 2012; 819():595-613. PubMed ID: 22183560
[TBL] [Abstract][Full Text] [Related]
7. Molecular Mechanism and Cannabinoid Pharmacology.
Schurman LD; Lu D; Kendall DA; Howlett AC; Lichtman AH
Handb Exp Pharmacol; 2020; 258():323-353. PubMed ID: 32236882
[TBL] [Abstract][Full Text] [Related]
8. Cannabis and the exocannabinoid and endocannabinoid systems. Their use and controversies.
Millán-Guerrero RO; Isais-Millán S
Gac Med Mex; 2019; 155(5):471-474. PubMed ID: 32091020
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive Review of Medicinal Marijuana, Cannabinoids, and Therapeutic Implications in Medicine and Headache: What a Long Strange Trip It's Been ….
Baron EP
Headache; 2015 Jun; 55(6):885-916. PubMed ID: 26015168
[TBL] [Abstract][Full Text] [Related]
10. One-pot heterogeneous synthesis of Δ(3)-tetrahydrocannabinol analogues and xanthenes showing differential binding to CB(1) and CB(2) receptors.
Rosati O; Messina F; Pelosi A; Curini M; Petrucci V; Gertsch J; Chicca A
Eur J Med Chem; 2014 Oct; 85():77-86. PubMed ID: 25072877
[TBL] [Abstract][Full Text] [Related]
11. Cannabinoids as therapeutic agents in cardiovascular disease: a tale of passions and illusions.
Mendizábal VE; Adler-Graschinsky E
Br J Pharmacol; 2007 Jun; 151(4):427-40. PubMed ID: 17450170
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic Use of Synthetic Cannabinoids: Still an OpenIssue?
De Luca MA; Fattore L
Clin Ther; 2018 Sep; 40(9):1457-1466. PubMed ID: 30180974
[TBL] [Abstract][Full Text] [Related]
13. Cannabis and its constituents for cancer: History, biogenesis, chemistry and pharmacological activities.
Lal S; Shekher A; Puneet ; Narula AS; Abrahamse H; Gupta SC
Pharmacol Res; 2021 Jan; 163():105302. PubMed ID: 33246167
[TBL] [Abstract][Full Text] [Related]
14. Isolation of a High-Affinity Cannabinoid for the Human CB1 Receptor from a Medicinal
Linciano P; Citti C; Luongo L; Belardo C; Maione S; Vandelli MA; Forni F; Gigli G; Laganà A; Montone CM; Cannazza G
J Nat Prod; 2020 Jan; 83(1):88-98. PubMed ID: 31891265
[TBL] [Abstract][Full Text] [Related]
15. Cannabis: A Toxin-Producing Plant with Potential Therapeutic Uses.
Breijyeh Z; Jubeh B; Bufo SA; Karaman R; Scrano L
Toxins (Basel); 2021 Feb; 13(2):. PubMed ID: 33562446
[TBL] [Abstract][Full Text] [Related]
16. The cannabinoid system and immune modulation.
Klein TW; Newton C; Larsen K; Lu L; Perkins I; Nong L; Friedman H
J Leukoc Biol; 2003 Oct; 74(4):486-96. PubMed ID: 12960289
[TBL] [Abstract][Full Text] [Related]
17. Cannabis y los sistemas exocannabinoide y endocannabinoide. Su uso y controversias.
Millán-Guerrero RO; Isais-Millán S
Gac Med Mex; 2019; 155(5):508-512. PubMed ID: 31695229
[TBL] [Abstract][Full Text] [Related]
18. Cannabinoids in the treatment of pain and spasticity in multiple sclerosis.
Smith PF
Curr Opin Investig Drugs; 2002 Jun; 3(6):859-64. PubMed ID: 12137404
[TBL] [Abstract][Full Text] [Related]
19. CB1 cannabinoid receptors mediate endochondral skeletal growth attenuation by Δ9-tetrahydrocannabinol.
Wasserman E; Tam J; Mechoulam R; Zimmer A; Maor G; Bab I
Ann N Y Acad Sci; 2015 Jan; 1335():110-9. PubMed ID: 25573322
[TBL] [Abstract][Full Text] [Related]
20. Medicinal chemistry of cannabinoids.
Vemuri VK; Makriyannis A
Clin Pharmacol Ther; 2015 Jun; 97(6):553-8. PubMed ID: 25801236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
